People: Landec Corp (LNDC.OQ)

LNDC.OQ on NASDAQ Stock Exchange Global Select Market

18 Mar 2019
Change (% chg)

$0.12 (+0.98%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Frank, Frederick 

Mr. Frederick Frank is Independent Director of the Company. Mr. Frank is Chairman of the Board of Evolution Life Sciences Partners. Prior to joining Evolution Partners, Mr. Frank was Chairman of the Board of Burrill Securities. Prior to joining Burrill Securities, Mr. Frank was Vice Chairman of Peter J. Solomon Company (“Solomon”). Before joining Solomon, Mr. Frank was Vice Chairman of Lehman Brothers, Inc. (“Lehman”) and Barclays Capital. Before joining Lehman as a Partner in October 1969, Mr. Frank was co-director of research, as well as Vice President and Director of Smith Barney & Co. Incorporated. During his over 50 years on Wall Street, Mr. Frank has been involved in numerous financings and merger and acquisition transactions. He serves as an advisor to the board of directors of PDL BioPharma, and was a director for the Institute for Systems Biology and Pharmaceutical Product Development, Inc. Mr. Frank is Chairman of the National Genetics Foundation and he serves on the Advisory Boards for Yale School of Organization and Management, the Massachusetts Institute of Technology Center of Biomedical Innovation and was formerly an Advisory Member of the Johns Hopkins Bloomberg School of Public Health, and the Harvard School of Public Health. He is a graduate of Yale University, received an M.B.A. from Stanford University and is a Chartered Financial Analyst.

Basic Compensation

Total Annual Compensation, USD 62,500
Restricted Stock Award, USD 60,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 122,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Steven Goldby


Molly Hemmeter


Gregory Skinner


James Hall


Steven Bitler


Albert Bolles

As Of  27 May 2018